Sort
64,565 grants matching “drug discovery”
Molecular recognition of proteins by antibodies: A model for rational design
$522,806Sandra Smith-Gill · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
RNA Targeted Drug Discovery and Development for Parkinson Disease
$522,761M. Maral Mouradian · Rbhs-Robert Wood Johnson Medical School · UG3 · FY2020 · NS
Project 2 Human Tumor Analysis
$522,720Sylvia Katina Plevritis · Stanford University · U54 · FY2023 · CA
Research Training in Academic Medical Oncology
$522,717Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2019 · CA
HIV-1 Preintegration Trafficking and Nuclear Localization
$522,706Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2018 · AI
Human Genetic Variance and Cellular Responses to Sexually Transmitted Infections
$522,643Dennis Chun-Yone Ko · University Of Maryland Baltimore · U19 · FY2014 · AI
Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows
$522,620Gary S Sayler · 490 Biotech, Inc. · R44 · FY2017 · GM
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
$522,605Rong Huang · Purdue University · R01 · FY2025 · CA
PGRN Administrative Coordination Hub, ACH (PGRN)
$522,571Kathleen M Giacomini · University Of California, San Francisco · U24 · FY2018 · GM
Development of a Combined MRI-PET System for Contemporaneous Functional Imaging
$522,513Raymond Robert Raylman · West Virginia University · R01 · FY2010 · EB
Iron independent role for yersiniabactin in Yersinia pestis
$522,510Matthew Lawrenz · University Of Louisville · R01 · FY2023 · AI
Gonadotropin-Releasing Hormone Action
$522,504P. Michael Conn · Oregon Health & Science University · R01 · FY2007 · HD
INITIAL FUNDING, RFP #N02-CM-37002-05, DTP-13-015, 02/01/2013 - 01/31/2014, SHE
$522,467Phd, Jonathan White · Midwest Research Institute · N02 · FY2013 · CA
Gonadotropin-Releasing Hormone Action
$522,439P. Michael Conn · Oregon Health & Science University · R01 · FY2006 · HD
A Combined Approach to Targeted Antiherpesvirus Drugs
$522,379Harvard University (Medical School) · R01 · FY2005 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease
$522,353Eric Joseph Rubin · Global Alliance For Tb Drug Development · U19 · FY2020 · AI
L-Cystine Diamides as Inhibitors of L-Cystine Stone Formation in Cystinuria
$522,334Amrik Sahota · Rutgers, The State Univ Of N.J. · R01 · FY2021 · DK
Retrovirus Budding and Endosomal Sorting
$522,307Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
New Approaches to Catalyst Screening and Development
$522,208David S Hage · University Of Nebraska-Lincoln · · FY2018 · ENG
Administrative Core
$522,176David S Perlin · Hackensack University Medical Center · U19 · FY2021 · AI
Target Selection and Ligand Discovery
$522,137Frederick Simmons Buckner · University Of Washington · P01 · FY2008 · AI
Small Molecule Drug Discovery for CLN3 and CLN6 Disease
$522,114Paul Trippier · University Of Nebraska Medical Center · R01 · FY2022 · HD
Mitochondrial therapeutics for healthy brain aging
$522,065Ronald L Davis · University Of Florida · R33 · FY2024 · AG
Integrators of Metastatic Potential
$522,054Pradipta Ghosh · University Of California, San Diego · R01 · FY2019 · CA
AutoDock Suite: High Performance Software Environment for Drug Design
$522,004Stefano Forli · Scripps Research Institute, The · R01 · FY2023 · GM